These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 1335069

  • 1. Muscarinic receptor subtypes in human neuroblastoma cell lines SH-SY5Y and IMR-32 as determined by receptor binding, Ca++ mobilization and northern blotting.
    Kukkonen J, Ojala P, Näsman J, Hämäläinen H, Heikkilä J, Akerman KE.
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1487-93. PubMed ID: 1335069
    [Abstract] [Full Text] [Related]

  • 2. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S, Buckley NJ, Roberts FF.
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [Abstract] [Full Text] [Related]

  • 3. Apparent noncompetitive antagonism of muscarinic receptor mediated Ca2+ mobilization by some muscarinic antagonists.
    Kukkonen J, Akerman KE.
    Biochem Biophys Res Commun; 1992 Dec 15; 189(2):919-24. PubMed ID: 1472064
    [Abstract] [Full Text] [Related]

  • 4. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
    Fisher SK.
    Mol Pharmacol; 1988 Apr 15; 33(4):414-22. PubMed ID: 3357485
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites.
    Cioffi CL, el-Fakahany EE.
    J Pharmacol Exp Ther; 1986 Sep 15; 238(3):916-23. PubMed ID: 3018226
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interaction of organophosphorus compounds with muscarinic receptors in SH-SY5Y human neuroblastoma cells.
    Ehrich M, Intropido L, Costa LG.
    J Toxicol Environ Health; 1994 Sep 15; 43(1):51-63. PubMed ID: 8078092
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular and pharmacological characterization of muscarinic receptor subtypes in a rat parotid gland cell line: comparison with native parotid gland.
    Bockman CS, Bradley ME, Dang HK, Zeng W, Scofield MA, Dowd FJ.
    J Pharmacol Exp Ther; 2001 May 15; 297(2):718-26. PubMed ID: 11303063
    [Abstract] [Full Text] [Related]

  • 11. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
    McKinney M, Stenstrom S, Richelson E.
    Mol Pharmacol; 1985 Feb 15; 27(2):223-35. PubMed ID: 2982089
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Muscarinic receptor binding characteristics of a human neuroblastoma SK-N-SH and its clones SH-SY5Y and SH-EP1.
    Lambert DG, Ghataorre AS, Nahorski SR.
    Eur J Pharmacol; 1989 Jun 08; 165(1):71-7. PubMed ID: 2767136
    [Abstract] [Full Text] [Related]

  • 14. Muscarinic receptor coupling to intracellular calcium release in rat pancreatic acinar carcinoma.
    Chien JL, Warren JR.
    Cancer Res; 1986 Nov 08; 46(11):5706-14. PubMed ID: 3756918
    [Abstract] [Full Text] [Related]

  • 15. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
    Brown JH, Goldstein D, Masters SB.
    Mol Pharmacol; 1985 May 08; 27(5):525-31. PubMed ID: 2581122
    [Abstract] [Full Text] [Related]

  • 16. Presence of m3 subtype muscarinic acetylcholine receptors and receptor-mediated increases in the cytoplasmic concentration of Ca2+ in Jurkat, a human leukemic helper T lymphocyte line.
    Kaneda T, Kitamura Y, Nomura Y.
    Mol Pharmacol; 1993 Mar 08; 43(3):356-64. PubMed ID: 8383801
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115): cyclic GMP formation is mediated by a low affinity agonist-receptor conformation and cyclic AMP reduction is mediated by a high affinity agonist-receptor conformation.
    McKinney M, Richelson E.
    Mol Pharmacol; 1986 Sep 08; 30(3):207-11. PubMed ID: 3018477
    [Abstract] [Full Text] [Related]

  • 19. Analysis of cardiac muscarinic receptors recognized selectively by nonquaternary but not by quaternary ligands.
    Brown JH, Goldstein D.
    J Pharmacol Exp Ther; 1986 Aug 08; 238(2):580-6. PubMed ID: 3016242
    [Abstract] [Full Text] [Related]

  • 20. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M, Waelbroeck M, Christophe J.
    Mol Pharmacol; 1987 Jul 08; 32(1):100-8. PubMed ID: 3600611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.